118 related articles for article (PubMed ID: 23913502)
1. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.
Mamlouk S; Kalucka J; Singh RP; Franke K; Muschter A; Langer A; Jakob C; Gassmann M; Baretton GB; Wielockx B
Int J Cancer; 2014 Feb; 134(4):849-58. PubMed ID: 23913502
[TBL] [Abstract][Full Text] [Related]
2. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
[TBL] [Abstract][Full Text] [Related]
3. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
4. Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.
Garrido G; Rabasa A; Garrido C; López A; Chao L; García-Lora AM; Garrido F; Fernández LE; Sánchez B
Oncogene; 2014 Jun; 33(24):3129-39. PubMed ID: 23975426
[TBL] [Abstract][Full Text] [Related]
5. Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.
Agrawal V; Maharjan S; Kim K; Kim NJ; Son J; Lee K; Choi HJ; Rho SS; Ahn S; Won MH; Ha SJ; Koh GY; Kim YM; Suh YG; Kwon YG
Oncotarget; 2014 May; 5(9):2761-77. PubMed ID: 24811731
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.
Kohanbash G; McKaveney K; Sakaki M; Ueda R; Mintz AH; Amankulor N; Fujita M; Ohlfest JR; Okada H
Cancer Res; 2013 Nov; 73(21):6413-23. PubMed ID: 24030977
[TBL] [Abstract][Full Text] [Related]
7. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.
Su Y; Loos M; Giese N; Metzen E; Büchler MW; Friess H; Kornberg A; Büchler P
Cancer; 2012 Feb; 118(4):960-72. PubMed ID: 21792862
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
9. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.
Chen EP; Markosyan N; Connolly E; Lawson JA; Li X; Grant GR; Grosser T; FitzGerald GA; Smyth EM
Carcinogenesis; 2014 Aug; 35(8):1788-97. PubMed ID: 24590894
[TBL] [Abstract][Full Text] [Related]
10. Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice.
Tabbekh M; Franciszkiewicz K; Haouas H; Lécluse Y; Benihoud K; Raman C; Mami-Chouaib F
J Immunol; 2011 Jul; 187(1):102-9. PubMed ID: 21622855
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of metastasis of B16F-10 melanoma cells in C57BL/6 mice by an extract of Calendula officinalis L flowers.
Preethi KC; Siveen KS; Kuttan R; Kuttan G
Asian Pac J Cancer Prev; 2010; 11(6):1773-9. PubMed ID: 21338232
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization.
Small DM; Burden RE; Jaworski J; Hegarty SM; Spence S; Burrows JF; McFarlane C; Kissenpfennig A; McCarthy HO; Johnston JA; Walker B; Scott CJ
Int J Cancer; 2013 Nov; 133(9):2102-12. PubMed ID: 23629809
[TBL] [Abstract][Full Text] [Related]
13. HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress.
Singh RP; Franke K; Kalucka J; Mamlouk S; Muschter A; Gembarska A; Grinenko T; Willam C; Naumann R; Anastassiadis K; Stewart AF; Bornstein S; Chavakis T; Breier G; Waskow C; Wielockx B
Blood; 2013 Jun; 121(26):5158-66. PubMed ID: 23667053
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of hematopoietic MUC1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cells.
Poh TW; Madsen CS; Gorman JE; Marler RJ; Leighton JA; Cohen PA; Gendler SJ
Clin Cancer Res; 2013 Sep; 19(18):5039-52. PubMed ID: 23873692
[TBL] [Abstract][Full Text] [Related]
15. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: roles of adipocytes and M2-macrophages.
Jung JI; Cho HJ; Jung YJ; Kwon SH; Her S; Choi SS; Shin SH; Lee KW; Park JH
Int J Cancer; 2015 Jan; 136(2):258-70. PubMed ID: 24844408
[TBL] [Abstract][Full Text] [Related]
16. Fusion-derived epithelial cancer cells express hematopoietic markers and contribute to stem cell and migratory phenotype in ovarian carcinoma.
Ramakrishnan M; Mathur SR; Mukhopadhyay A
Cancer Res; 2013 Sep; 73(17):5360-70. PubMed ID: 23856249
[TBL] [Abstract][Full Text] [Related]
17. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis.
Carmi Y; Rinott G; Dotan S; Elkabets M; Rider P; Voronov E; Apte RN
J Immunol; 2011 Mar; 186(6):3462-71. PubMed ID: 21300825
[TBL] [Abstract][Full Text] [Related]
18. Development of a metastatic fluorescent Lewis Lung carcinoma mouse model: identification of mRNAs and microRNAs involved in tumor invasion.
Rask L; Fregil M; Høgdall E; Mitchelmore C; Eriksen J
Gene; 2013 Mar; 517(1):72-81. PubMed ID: 23296057
[TBL] [Abstract][Full Text] [Related]
19. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
20. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
